Cargando…
Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series
Myelodysplastic Syndrome (MDS) with del(5q) represents a unique WHO entity, which is often treated with lenalidomide according to standard clinical practice. Guidelines concerning treatment duration have thus far not been implemented, but rather comprise an indefinite therapy until loss of response....
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008833/ https://www.ncbi.nlm.nih.gov/pubmed/35433412 http://dx.doi.org/10.3389/fonc.2022.866470 |